Moreover, COX-2 is frequently upregulated in cancer, making COX-2 a promising biomarker for cancer diagnosis and therapy, as demonstrated by the development of various fluorescent [49,50,51,52,53] and radioimaging probes over the last decades [54,55,56,57]. Here, PTGS2 is linked to cancer.